摘要
糖尿病 (DM) 是一种慢性疾病,对世界健康构成威胁。对抗疗法药物在控制 DM 及其并发症方面不够有效。因此,传统医学体系受到了很多关注。具有药用特性的植物衍生天然化合物在 DM 管理和治疗中发挥着重要作用。艾蒿是菊科的一个种类繁多且分布广泛的属,有 500 多个物种,具有有益的经济和治疗意义。 Science Direct、Scopus、Pubmed、Web of Science、medRixv 和 Wiley 等电子数据库用于搜索科学文献。在民间传说医学中,蒿属植物已被广泛用于糖尿病管理。分子研究表明,NF-κB 抑制、Notch 1 抑制、细胞周期在 S+G2/M 期停止、Bax 蛋白浓度增加、线粒体膜电位衰减、p53 和 caspase 的激活、Bcl-2 调节和 ROS形成是可以通过各种蒿属植物靶向的关键机制。单剂量或多剂量的蒿属植物酒精和水提取物的抗糖尿病作用是由于存在生物活性化合物,它们在实验检查中完全有效地降低血糖水平。尽管有可用的抗糖尿病药物,但从上述植物中获得的治疗剂已被用于治疗这种疾病及其并发症,而且副作用较小。综合起来,多条证据表明,蒿属植物可以作为潜在的治疗候选者用于糖尿病的治疗和管理。
关键词: 糖尿病,艾蒿,草药,分子途径,抗糖尿病潜力,菊科。
Current Molecular Medicine
Title:Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Volume: 21 Issue: 10
关键词: 糖尿病,艾蒿,草药,分子途径,抗糖尿病潜力,菊科。
摘要: Diabetes mellitus (DM) is a chronic disease and a threatening problem for world health. Allopathic medications are not efficient enough in controlling DM and its complications. Therefore, much attention has been directed towards the traditional medicine system. Plant derived-natural compounds with medicinal properties play an essential role in DM management and treatment. Artemisia is a varied and widespread genus of the family Asteraceae, which has more than 500 species with beneficial economic and therapeutic significance. Electronic databases such as Science Direct, Scopus, Pubmed, Web of Science, medRixv, and Wiley were used to search scientific literature. In folklore medicine, Artemisia species have been widely utilized for diabetes management. Molecular investigations have revealed that the NF-κB suppression, Notch 1 inhibition, cell cycle stop at S+G2/M-phase, enhanced Bax protein concentrations, mitochondrial membrane potential attenuation, activation of p53 and caspase, Bcl-2 regulation, and ROS formation are crucial mechanisms that could be targeted via various Artemisia species. Anti-diabetic effects of single or multiple doses of alcoholic and aqueous extracts of Artemisia species are due to the presence of bioactive compounds, and they are completely efficient in lowering levels of blood glucose in experimental examinations. In spite of the available anti-diabetic drugs, therapeutic agents obtained from the mentioned plants have been used for the treatment of this disease and its complications with less adverse impacts. Taken together, multiple lines of evidence indicated that Artemisia species could be introduced as a potential therapeutic candidate in the treatment and management of diabetes.
Export Options
About this article
Cite this article as:
Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1566524020999210101234317
DOI https://dx.doi.org/10.2174/1566524020999210101234317 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Peripartum Cardiomyopathy: An Intriguing Challenge. Case Report with Literature Review
Current Cardiology Reviews Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
Current Pharmaceutical Design Regulation of Sulfotransferases by Xenobiotic Receptors
Current Drug Metabolism Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design Atypical Antipsychotic Drugs During Pregnancy. Their Effects on the Mother and Offspring
Current Women`s Health Reviews Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma
Current Drug Delivery Heteroaromatization with 4-Phenyldiazenyl-1-naphthol. Part IV: Synthesis of Some New Heterocyclic Compounds with Potential Biological Activity
Current Organic Synthesis Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections
Coronaviruses Current Management and Treatment of Cerebral Vasospasm Complicating SAH
CNS & Neurological Disorders - Drug Targets Detection and Treatment of Alcohol-Induced Hypertension
Current Hypertension Reviews Antimicrobial Peptides from Anurans Skin Secretions
Protein & Peptide Letters Nebivolol: More Than a Highly Selective Beta Blocker
Recent Patents on Cardiovascular Drug Discovery Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications
Current Pharmaceutical Design Safety of Canagliflozin in Patients with Type 2 Diabetes
Current Drug Safety The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Medicinal Chemistry Reviews - Online (Discontinued) Pulmonary Complications After Congenital Heart Surgery
Current Respiratory Medicine Reviews Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets